Societies Change Term for Fatty Liver To Focus on Steatosis

After years of discussion and review, an international working group has announced recently that they will refer to ...

AUGUST 28, 2023

Multidisciplinary Program for Fatty Liver Disease Helps Patients Lose Weight

WASHINGTON—A multidisciplinary program for fatty liver disease can enable more referrals for bariatric ...

NOVEMBER 10, 2022

NASH Dash: The Pipeline Race is on for New Agents

The year 2022 could see, for the first time, FDA-approved medications for nonalcoholic steatohepatitis (NASH). ...

JANUARY 15, 2022

Hospitalized IBD Patients With NAFLD Have More Readmissions, Longer Stays

The combination of inflammatory bowel disease and fatty liver has been linked to worse outcomes for hospitalized ...

AUGUST 18, 2021

NAFLD Outcomes Worse for Blacks

Black patients hospitalized with nonalcoholic fatty liver disease are significantly more likely to die in the ...

AUGUST 11, 2021

Enzyme Inhibition Has Potential To Ameliorate Fatty Liver Disease

The protein-cleaving enzyme caspase-2 appears to be a key driver of non-alcoholic steatohepatitis, researchers in ...

OCTOBER 16, 2018

Metabolic Factors May Link NAFLD, Alcoholic Liver Disease

A single-center study conducted in Denmark has found a positive association between metabolic syndrome and ...

JUNE 25, 2018